(Q44072123)

English

8-(3-Chlorostyryl)caffeine may attenuate MPTP neurotoxicity through dual actions of monoamine oxidase inhibition and A2A receptor antagonism

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

8-(3-Chlorostyryl)caffeine may attenuate MPTP neurotoxicity through dual actions of monoamine oxidase inhibition and A2A receptor antagonism (English)

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

1 reference

based on heuristic

inferred from title

Jacobus P. Petzer

4

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

author name string

Jiang-Fan Chen

1

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Salome Steyn

2

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Roland Staal

3

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Kui Xu

5

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Cornelis J Van Der Schyf

6

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Kay Castagnoli

7

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Patricia K Sonsalla

8

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Neal Castagnoli

9

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Michael A Schwarzschild

10

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

language of work or name

0 references

publication date

18 July 2002

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

277

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

39

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

36040-36044

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Parkinson's disease. First of two parts

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206830200

21 January 2018

Caffeinated clues and the promise of adenosine A(2A) antagonists in PD.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206830200

21 January 2018

Association of coffee and caffeine intake with the risk of Parkinson disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206830200

21 January 2018

Prospective study of caffeine consumption and risk of Parkinson's disease in men and women.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206830200

21 January 2018

Neuroprotection by adenosine A2A receptor blockade in experimental models of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206830200

21 January 2018

8-(3-Chlorostyryl)caffeine (CSC) is a selective A2-adenosine antagonist in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206830200

21 January 2018

Animal models of Parkinson's disease: an empirical comparison with the phenomenology of the disease in man.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206830200

21 January 2018

Novel 4-(aryloxy)tetrahydropyridine analogs of MPTP as monoamine oxidase A and B substrates

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206830200

21 January 2018

Isolation and characterization of a monoamine oxidase inhibitor from tobacco leaves

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206830200

21 January 2018

Dramatic species differences in the susceptibility of monoamine oxidase B to a group of powerful inhibitors.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206830200

21 January 2018

Ultrastructural localization of adenosine A2A receptors suggests multiple cellular sites for modulation of GABAergic neurons in rat striatum

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206830200

21 January 2018

Adenosine A2A receptor antagonists are potential antidepressants: evidence based on pharmacology and A2A receptor knockout mice

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206830200

21 January 2018

Preparation and primary evaluation of [11C]CSC as a possible tracer for mapping adenosine A2A receptors by PET

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206830200

21 January 2018

Distribution of type B monoamine oxidase immunoreactivity in the cat brain with reference to enzyme histochemistry

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206830200

21 January 2018

Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M206830200

21 January 2018

Identifiers

10.1074/JBC.M206830200

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

29 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44072123&oldid=2106271015"